RecallRadar

FDA Drug recall D-017-2014

Acyclovir Tablets USP 800 mg ,(NDC 60505-5307-1), Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for…

On 2013-12-04 the FDA classified a Class II recall of Acyclovir Tablets USP 800 mg ,(NDC 60505-5307-1), Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for… by Apotex, citing presence of Particulate Matter: Product from lot KF2199, may contain tablets with pieces of nitrile rubber glove embedded within the tablets.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-017-2014
ClassificationClass II
Statusterminated
Initiated2013-07-17
Published2013-12-04
Last updated2026-09-13 11:51 UTC
CompanyApotex
DistributionUS

Product

Acyclovir Tablets USP 800 mg ,(NDC 60505-5307-1), Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for Apotex Corp.,Weston, Florida 33326.

Reason

Presence of Particulate Matter: Product from lot KF2199, may contain tablets with pieces of nitrile rubber glove embedded within the tablets.

Identifiers

ndc60505-5306-3
ndc60505-5306-1
ndc60505-5306-5
ndc60505-5306-8
ndc60505-5307-3
ndc60505-5307-1
ndc60505-5307-5
code_infoLot # KF2199 Exp 07/15

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-017-2014%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.